|
|
||||||||
Department of Neurology (Drs. O'Neill and Swanson), Mayo Clinic and Foundation, Rochester, MN; and the Departments of Pediatrics (Dr. Brown) and Neurology (Drs. Griffin and Moser), John F. Kennedy Institute, Johns Hopkins Medical Institutions, Baltimore, MD.
Adrenoleukodystrophy (ALD) must be considered in the diagnosis of men with progressive nervous system disease. We found the biochemical defect characteristic of ALD in two brothers with spastic paraparesis of late adult onset. Family study then revealed other affected men and asymptomatic heterozygotes in a pattern that conformed to an X-linked pattern of inheritance.
Address correspondence and reprint requests to Dr. O'Neill. Department of Neurology, Mayo Clinic and Foundation, Rochester, MN 55905.
Accepted for publication November 30, 1984.
This article has been cited by other articles:
![]() |
P. Aubourg, C. Adamsbaum, M.-C. Lavallard-Rousseau, F. Rocchiccioli, N. Cartier, I. Jambaque, C. Jakobezak, A. Lemaitre, F. Boureau, C. Wolf, et al. A Two-Year Trial of Oleic and Erucic Acids ("Lorenzo's Oil") as Treatment for Adrenomyeloneuropathy N. Engl. J. Med., September 9, 1993; 329(11): 745 - 752. [Abstract] [Full Text] |
||||
![]() |
M. J. Noetzel, W. M. Landau, and H. W. Moser Adrenoleukodystrophy Carrier State Presenting as a Chronic Nonprogressive Spinal Cord Disorder Arch Neurol, May 1, 1987; 44(5): 566 - 567. [Abstract] [PDF] |
||||
![]() |
C. R. Wells and J. Jankovic Familial Spastic Paraparesis and Deafness: A New X-linked Neurodegenerative Disorder Arch Neurol, September 1, 1986; 43(9): 943 - 946. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |